Literature DB >> 22815062

They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.

Joanna L Starrels1, Aaron D Fox, Hillary V Kunins, Chinazo O Cunningham.   

Abstract

BACKGROUND: Urine drug testing (UDT) can help identify misuse or diversion of opioid medications among patients with chronic pain. However, misinterpreting results can lead to false reassurance or erroneous conclusions about drug use.
OBJECTIVE: To examine the relationship between resident physicians' knowledge about UDT interpretation and confidence in their ability to interpret UDT results.
DESIGN: Cross-sectional survey. PARTICIPANTS: Internal medicine residents in a university health system in the Bronx, from 2010 to 2011. MAIN MEASURES: We assessed knowledge using a 7-item scale (UDT knowledge score), and confidence in UDT interpretation using a single statement ("I feel confident in my ability to interpret the results of urine drug tests"). We conducted chi-square tests, t-tests, and logistic regression to determine the association between knowledge and confidence, and in exploratory analyses to examine whether resident characteristics (gender, training level, and UDT use) moderated the relationship between knowledge and confidence. KEY
RESULTS: Among 99 residents, the mean UDT knowledge score was 3.0 out of 7 (SD 1.2). Although 55 (56 %) of residents felt confident in their ability to interpret UDT results, 40 (73 %) of confident residents had a knowledge score of 3 or lower. Knowledge score was not associated with confidence among the full sample or when stratified by training level or UDT use. The association between knowledge and confidence differed significantly by gender (interaction term p<0.01). Adjusting for training level and UDT use, knowledge was positively associated with confidence among females (AOR 1.79, 95 % CI: 1.06, 3.30), and negatively associated with confidence among males (AOR 0.47, 95 % CI: 0.23, 0.98).
CONCLUSIONS: Despite poor knowledge about UDT interpretation, most resident physicians felt confident in their ability to interpret UDT results. Gender differences warrant further exploration, but even confident physicians who use UDT should evaluate their proficiency in interpreting UDT results. Educational initiatives should emphasize the complexities of UDT interpretation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815062      PMCID: PMC3475838          DOI: 10.1007/s11606-012-2165-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  37 in total

1.  Important demographic variables impact the musculoskeletal knowledge and confidence of academic primary care physicians.

Authors:  Joseph R Lynch; Gregory A Schmale; Douglas C Schaad; Seth S Leopold
Journal:  J Bone Joint Surg Am       Date:  2006-07       Impact factor: 5.284

2.  Assessment of musculoskeletal knowledge in primary care residents.

Authors:  Brett L Haywood; Steven L Porter; William A Grana
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2006-06

3.  Self-assessment in lifelong learning and improving performance in practice: physician know thyself.

Authors:  F Daniel Duffy; Eric S Holmboe
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

4.  Family physicians' proficiency in urine drug test interpretation.

Authors:  Gary M Reisfield; Fern J Webb; Roger L Bertholf; Paul A Sloan; George R Wilson
Journal:  J Opioid Manag       Date:  2007 Nov-Dec

5.  Prescription opioids, overdose deaths, and physician responsibility.

Authors:  A Thomas McLellan; Barbara Turner
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

Review 6.  Overconfidence as a cause of diagnostic error in medicine.

Authors:  Eta S Berner; Mark L Graber
Journal:  Am J Med       Date:  2008-05       Impact factor: 4.965

7.  The role of urine drug testing for patients on opioid therapy.

Authors:  Joseph Pergolizzi; Macro Pappagallo; Joseph Stauffer; Christopher Gharibo; Neil Fortner; Mathew N De Jesus; Michael J Brennan; Charlotte Richmond; Desmond Hussey
Journal:  Pain Pract       Date:  2010 Nov-Dec       Impact factor: 3.183

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Drug testing of adolescents in ambulatory medicine: physician practices and knowledge.

Authors:  Sharon Levy; Sion Kim Harris; Lon Sherritt; Michelle Angulo; John R Knight
Journal:  Arch Pediatr Adolesc Med       Date:  2006-02

10.  Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective.

Authors:  Stacy E F Melanson; Maria I Kredlow; Petr Jarolim
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

View more
  18 in total

1.  Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.

Authors:  Jessica J Wyse; Benjamin J Morasco; Steven K Dobscha; Michael I Demidenko; Thomas H A Meath; Travis I Lovejoy
Journal:  J Opioid Manag       Date:  2018 Jul/Aug

Review 2.  Laboratory testing for prescription opioids.

Authors:  Michael C Milone
Journal:  J Med Toxicol       Date:  2012-12

3.  Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings.

Authors:  Rachel Ceasar; Jamie Chang; Kara Zamora; Emily Hurstak; Margot Kushel; Christine Miaskowski; Kelly Knight
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

4.  Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients.

Authors:  Julie R Gaither; Kirsha Gordon; Stephen Crystal; E Jennifer Edelman; Robert D Kerns; Amy C Justice; David A Fiellin; William C Becker
Journal:  Drug Alcohol Depend       Date:  2018-08-06       Impact factor: 4.492

5.  Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?

Authors:  Marc R Larochelle; Ricardo Cruz; Sarah Kosakowski; Doug L Gourlay; Daniel P Alford; Ziming Xuan; Erin E Krebs; Shapei Yan; Karen E Lasser; Jeffrey H Samet; Jane M Liebschutz
Journal:  J Gen Intern Med       Date:  2021-08-17       Impact factor: 6.473

6.  Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine Resident Practices.

Authors:  Payel Roy; Angela H Jackson; Jeffrey Baxter; Belle Brett; Michael Winter; Ilana Hardesty; Daniel P Alford
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750

Review 7.  Urine Drug Testing in Cancer Pain Management.

Authors:  Joseph A Arthur
Journal:  Oncologist       Date:  2019-10-11

8.  Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids.

Authors:  Joji Suzuki; Stephanie Garayalde; Martekuor Dodoo; Claudia Rodriguez
Journal:  Subst Abus       Date:  2018-10-16       Impact factor: 3.716

9.  Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

Authors:  Isaac Chua; Athena K Petrides; Gordon D Schiff; Jaime R Ransohoff; Michalis Kantartjis; Jocelyn Streid; Christiana A Demetriou; Stacy E F Melanson
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

10.  The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.

Authors:  Julie R Gaither; Joseph L Goulet; William C Becker; Stephen Crystal; E Jennifer Edelman; Kirsha Gordon; Robert D Kerns; David Rimland; Melissa Skanderson; Amy C Justice; David A Fiellin
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.